These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7870912)

  • 21. Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment.
    Hommer D; Weingartner H; Breier A
    Psychopharmacology (Berl); 1993; 112(4):455-60. PubMed ID: 7871057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of moclobemide to improve cerebral insufficiency identified using a scopolamine model of aging and dementia.
    Wesnes K; Anand R; Lorscheid T
    Acta Psychiatr Scand Suppl; 1990; 360():71-2. PubMed ID: 2248080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of scopolamine-induced amnesia in mice.
    Stone WS; Croul CE; Gold PE
    Psychopharmacology (Berl); 1988; 96(3):417-20. PubMed ID: 3146778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory.
    Ghoneim MM; Mewaldt SP
    Psychopharmacologia; 1975 Nov; 44(3):257-62. PubMed ID: 1208760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.
    Yamaguchi Y; Kobayashi H
    Neuropeptides; 1994 Mar; 26(3):153-8. PubMed ID: 8208360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nootropic drugs in a scopolamine-induced amnesia model in mice.
    Verloes R; Scotto AM; Gobert J; Wülfert E
    Psychopharmacology (Berl); 1988; 95(2):226-30. PubMed ID: 3137602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.
    Patat A; Klein MJ; Surjus A; Hucher M; Granier J
    Eur J Clin Pharmacol; 1991; 41(3):225-31. PubMed ID: 1684155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35,926 (CI-979).
    M'Harzi M; Palou AM; Oberlander C; Barzaghi F
    Pharmacol Biochem Behav; 1995 May; 51(1):119-24. PubMed ID: 7617721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anterograde amnesia with oral lorazepam.
    Mac DS; Kumar R; Goodwin DW
    J Clin Psychiatry; 1985 Apr; 46(4):137-8. PubMed ID: 3980452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.
    Ammassari-Teule M; Castellano C; Sansone M
    Behav Brain Res; 1992 Mar; 47(1):93-5. PubMed ID: 1571105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diazepam-induced amnesia: a neuropharmacological model of an "organic amnestic syndrome".
    Wolkowitz OM; Weingartner H; Thompson K; Pickar D; Paul SM; Hommer DW
    Am J Psychiatry; 1987 Jan; 144(1):25-9. PubMed ID: 3799835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttraining administration of gastrin-releasing peptide improves memory loss in scopolamine- and hypoxia-induced amnesic mice.
    Santo-Yamada Y; Yamada K; Wada K
    Physiol Behav; 2001 Sep 1-15; 74(1-2):139-43. PubMed ID: 11564462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group.
    Parnetti L; Mecocci P; Petrini A; Longo A; Buccolieri A; Senin U
    Neuropsychobiology; 1989; 22(2):97-100. PubMed ID: 2518332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Nootropic drugs and brain acetylcholine.
    Pepeu G; Spignoli G; Giovannini MG; Magnani M
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():116-9. PubMed ID: 2602443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming and recall.
    Schifano F; Curran HV
    Psychopharmacology (Berl); 1994 Jul; 115(3):430-4. PubMed ID: 7871085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration.
    Pomara N; Facelle TM; Roth AE; Willoughby LM; Greenblatt DJ; Sidtis JJ
    Psychopharmacology (Berl); 2006 May; 185(4):487-94. PubMed ID: 16525857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral physostigmine and impaired memory in adults with brain injury.
    Cardenas DD; McLean A; Farrell-Roberts L; Baker L; Brooke M; Haselkorn J
    Brain Inj; 1994 Oct; 8(7):579-87. PubMed ID: 7804294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task.
    Azami NS; Piri M; Oryan S; Jahanshahi M; Babapour V; Zarrindast MR
    Neurobiol Learn Mem; 2010 May; 93(4):455-62. PubMed ID: 20064624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
    FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
    Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.